Open Access and Peer-reviewed
Home Journal Issues Guide for Authors Editorial Board Aims & Scope About Journal News & Announcements


Review Article 


Experimental efficacy evaluation of inactivated and live Newcastle disease virus vaccines of genotypes II and VII against wild type virus

Karim M Selim, Abdullah A Selim, abdelsattar Arafa, Hussein Aly Hussein, Ahmed A El-Sanousi.

Abstract
Background: Different genotypes of Avian avulavirus 1, also known as Newcastle disease virus (NDV) and formerly known as Avian paramyxovirus 1(APMV-1), are circulating in many parts of the world. Currently, the used vaccine strains (mainly genotypes I and II) are three to seven decades old and are genetically distant from the currently circulating virulent Newcastle disease virus (NDV).
Objectives: In this study, we compared two vaccination programs against NDV in chickens, one using genotype VII inactivated and live NDV vaccine are available in the market, and the second group used genotype II inactivated LaSota vaccine with a live vaccine.
Method: NDV isolate designated NDV-GZ-986F-2015 was isolated from a commercial broiler farm in Egypt and characterized as a virulent strain that was used for the challenge. Contact chicks were added in both groups post-challenge.
Results: indicated that both programs can protect birds from mortalities (up to 100 %). The parameters used in this evaluation are the antibody immune response using hemagglutination inhibition (HI) assay, protection post-challenge, virus shedding and transmission in contact non-vaccinated chickens using the qRT-PCR test. The genotype VII (GVII) vaccine group induced higher HI titer by using GVII monospecific antigen and decreased virus shedding than other groups. The vaccinated group with genotype VII significantly reduced the virus shedding at 3, 5, 7, and 10 days post-challenge unlike the genotype II vaccinated group that did not reduce virus shedding and increased morbidity and mortality in contact birds.
Conclusion: The combined inactivated and live NDV vaccination programs have the potency to prevent mortalities of virulent genotype VII challenge virus. The vaccination program used genotype VII inactivated and live vaccines initiated a high level of antibody titers that can limit the transmission and virus shedding to the contact birds. These results may help in controlling the NDV of GVII virulent strain that is commonly circulating in the field.

Key words: Newcastle disease virus, homologues and heterologous Vaccination program, Virus shedding, GII, GVII, Recombinant Lasota vaccine


 
ARTICLE TOOLS
Abstract
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Karim M Selim
Articles by Abdullah A Selim
Articles by abdelsattar Arafa
Articles by Hussein Aly Hussein
Articles by Ahmed A El-Sanousi
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Selim KM, Selim AA, Arafa a, Hussein HA, El-Sanousi AA. Experimental efficacy evaluation of inactivated and live Newcastle disease virus vaccines of genotypes II and VII against wild type virus. JVS. 2020; 8(1): 1-11.


Web Style

Selim KM, Selim AA, Arafa a, Hussein HA, El-Sanousi AA. Experimental efficacy evaluation of inactivated and live Newcastle disease virus vaccines of genotypes II and VII against wild type virus. http://www.j-virol-sci.com/?mno=112992 [Access: December 21, 2020].


AMA (American Medical Association) Style

Selim KM, Selim AA, Arafa a, Hussein HA, El-Sanousi AA. Experimental efficacy evaluation of inactivated and live Newcastle disease virus vaccines of genotypes II and VII against wild type virus. JVS. 2020; 8(1): 1-11.



Vancouver/ICMJE Style

Selim KM, Selim AA, Arafa a, Hussein HA, El-Sanousi AA. Experimental efficacy evaluation of inactivated and live Newcastle disease virus vaccines of genotypes II and VII against wild type virus. JVS. (2020), [cited December 21, 2020]; 8(1): 1-11.



Harvard Style

Selim, K. M., Selim, . A. A., Arafa, . a., Hussein, . H. A. & El-Sanousi, . A. A. (2020) Experimental efficacy evaluation of inactivated and live Newcastle disease virus vaccines of genotypes II and VII against wild type virus. JVS, 8 (1), 1-11.



Turabian Style

Selim, Karim M, Abdullah A Selim, abdelsattar Arafa, Hussein Aly Hussein, and Ahmed A El-Sanousi. 2020. Experimental efficacy evaluation of inactivated and live Newcastle disease virus vaccines of genotypes II and VII against wild type virus. Journal of Virological Sciences, 8 (1), 1-11.



Chicago Style

Selim, Karim M, Abdullah A Selim, abdelsattar Arafa, Hussein Aly Hussein, and Ahmed A El-Sanousi. "Experimental efficacy evaluation of inactivated and live Newcastle disease virus vaccines of genotypes II and VII against wild type virus." Journal of Virological Sciences 8 (2020), 1-11.



MLA (The Modern Language Association) Style

Selim, Karim M, Abdullah A Selim, abdelsattar Arafa, Hussein Aly Hussein, and Ahmed A El-Sanousi. "Experimental efficacy evaluation of inactivated and live Newcastle disease virus vaccines of genotypes II and VII against wild type virus." Journal of Virological Sciences 8.1 (2020), 1-11. Print.



APA (American Psychological Association) Style

Selim, K. M., Selim, . A. A., Arafa, . a., Hussein, . H. A. & El-Sanousi, . A. A. (2020) Experimental efficacy evaluation of inactivated and live Newcastle disease virus vaccines of genotypes II and VII against wild type virus. Journal of Virological Sciences, 8 (1), 1-11.








AUTHOR LOGIN

REVIEWER LOGIN

Indexed
&
Abstracted



ABOUT JOURNAL
POLICIES
STATEMENTS

This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.

The articles in Journal of Virological Sciences are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.